BIOLOGICAL PROGNOSTIC FACTORS IN NONSMALL CELL LUNG-CANCER

被引:0
|
作者
SCAGLIOTTI, GV
MASIERO, P
POZZI, E
机构
关键词
NONSMALL CELL LUNG CANCER; PROGNOSTIC FACTORS; PROLIFERATIVE ACTIVITY; ONCOGENES; ANTIONCOGENES; GROWTH FACTORS; GROWTH FACTOR RECEPTORS; METALLOPROTEINASES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The results of conventional treatments for lung cancer remain poor and long-term survival rates have changed little over the last 10 years. In the same period of time there has been an explosion in the knowledge on the processes of cellular transformation, tumour progression, invasion and metastasis. The major categories of biological events implicated in non-small cell lung cancer include growth factor receptors expression (epidermal growth factor receptor, p185(c-neu)), autocrine growth factor production (transforming growth factor alpha), dominant oncogenes activation (ras genes) and deletion of tumour suppressor genes (p53 gene, retinoblastoma gene) and these are some of the abnormalities associated with specific histological types and with poor prognosis. Additional prognostic information can be obtained from the evaluation of the ploidy and proliferative activity of the tumours, carbohydrate antigens expression, presence of neuroendocrine differentiation and the evaluation of markers of the sequential steps involved in the process of tumour dissemination.
引用
收藏
页码:S13 / S25
页数:13
相关论文
共 50 条
  • [1] PROGNOSTIC FACTORS IN NONSMALL CELL LUNG-CANCER
    FELD, R
    BORGES, M
    GINER, V
    GINSBERG, R
    HARPER, P
    KLASTERSKY, J
    LACQUET, L
    PAESMANS, M
    PAYNE, D
    ROSELL, R
    SAUSE, W
    SCULIER, JP
    SHAW, E
    SORENSEN, JB
    SPLINTER, T
    STAHEL, R
    BUNN, P
    LUNG CANCER, 1994, 11 : S19 - S23
  • [2] PROGNOSTIC ISSUES IN NONSMALL CELL LUNG-CANCER
    HARPOLE, DH
    CHEST, 1995, 107 (06) : S267 - S269
  • [3] PROGNOSTIC FACTORS IN LOCOREGIONAL NONSMALL CELL LUNG-CANCER TREATED WITH RADIOTHERAPY
    COEN, V
    VANLANCKER, M
    DENEVE, W
    STORME, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (02): : 111 - 117
  • [5] NEUROENDOCRINE DIFFERENTIATION AS A PROGNOSTIC FACTOR IN NONSMALL CELL LUNG-CANCER
    CARLES, J
    ROSELL, R
    ARIZA, A
    PELLICER, I
    SANCHEZ, JJ
    FERNANDEZVASALO, G
    ABAD, A
    BARNADAS, A
    LUNG CANCER, 1993, 10 (3-4) : 209 - 219
  • [6] THERAPY OF NONSMALL CELL LUNG-CANCER
    KLASTERSKY, J
    LUNG CANCER, 1995, 12 : S133 - S145
  • [7] STAGING NONSMALL CELL LUNG-CANCER
    ARMSTRONG, P
    VINCENT, JM
    CLINICAL RADIOLOGY, 1993, 48 (01) : 1 - 10
  • [8] GEMCITABINE IN NONSMALL CELL LUNG-CANCER
    SORENSEN, JB
    LUNG CANCER, 1995, 12 : S173 - S175
  • [9] CHEMOTHERAPY OF NONSMALL CELL LUNG-CANCER
    MCVIE, JG
    ANNALS OF ONCOLOGY, 1993, 4 (10) : 804 - 805
  • [10] PROGNOSTIC FACTORS IN SMALL CELL LUNG-CANCER
    MANEGOLD, C
    BULZEBRUCK, H
    DRINGS, P
    VOGTMOYKOPF, I
    ONKOLOGIE, 1989, 12 (05): : 240 - &